## **Core Concept**
Multiple Sclerosis (MS) is a chronic autoimmune disease characterized by demyelination in the central nervous system (CNS). The treatment of MS involves disease-modifying therapies (DMTs) that aim to reduce inflammation, slow disease progression, and manage symptoms. Various medications are used to treat MS, including interferons, glatiramer acetate, and more recently, monoclonal antibodies and oral therapies.

## **Why the Correct Answer is Right**
The correct answer, , refers to a medication used in the treatment of Multiple Sclerosis. **Glatiramer acetate** is a disease-modifying therapy for MS. It works by modifying or interrupting the immune system's attack on the protective covering of nerves, thereby reducing the frequency of relapses. Glatiramer acetate is believed to act as an immunomodulator, possibly by affecting the function of T cells. It is administered via subcutaneous injection.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option does not correspond to a recognized treatment for Multiple Sclerosis.
- **Option B:** This option does not represent a standard therapy for MS.
- **Option D:** This option is not a commonly used treatment for Multiple Sclerosis.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Glatiramer acetate** is one of the first-line treatments for relapsing forms of Multiple Sclerosis. It has a relatively favorable side effect profile compared to some other DMTs, although it can cause chest tightness, palpitations, and anxiety in some patients.

## **Correct Answer:** . Glatiramer Acetate